SCHEMBL16626935

SCHEMBL16626935

CCOP(=O)(OCC)c1cn[nH]c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.37
HTR2B P41595 1/20 0.37
KCNH2 Q12809 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TSHR P16473 2/20 0.34
LMNA P02545 1/20 0.34
APEX1 P27695 1/20 0.34
PMP22 Q01453 1/20 0.34
POLB P06746 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ACHE P22303 1/20 0.33
TP53 P04637 1/20 0.32
CCNT1 O60563 1/20 0.32
CDK9 P50750 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12230156 0.72 TSHR (0.37) HTR2AHTR2BKCNH2TDP1MEN1
SCHEMBL6829825 0.72 TDP1 (0.49) HTR2AHTR2BKCNH2TDP1MEN1
SCHEMBL2208990 0.68 KDM4E (0.43) TDP1MEN1KMT2ATSHRPOLB
SCHEMBL23732865 0.68 NOS2 (0.41) KCNH2TSHRKDM4E
SCHEMBL8047204 0.67 RAB9A (0.48) HTR2AHTR2BTDP1MEN1KMT2A
SCHEMBL358474 0.67 MEN1 (0.59) KCNH2TDP1MEN1KMT2ALMNA
SCHEMBL9407115 0.67 TDP1 (0.45) HTR2AHTR2BKCNH2TDP1MEN1
SCHEMBL1243824 0.67 KCNA5 (0.47) MEN1KMT2AACHECA12CA1
SCHEMBL31482560 0.67 KCNA5 (0.47) MEN1KMT2AACHECA12CA1
SCHEMBL13459312 0.67 KDM4E (0.41) HTR2AHTR2BTDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235911-A2 INHIBIN SUBUNIT BETA E-RELATED DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO WAVE LIFE SCIENCES LTD. (SG) 2025-11-13 WO disclosed
US-20220220134-A1 PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2022-07-14 US disclosed
US-10351581-B2 Phosphohistidine mimetics and antibodies to same THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2019-07-16 US disclosed
US-20190092796-A1 PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2019-03-28 US disclosed
US-20160311838-A1 PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME THE TRUSTEES OF PRINCETON UNIVERSITY 2016-10-27 US disclosed
WO-2015051079-A2 PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190092796-A1 PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME PHPT1, CD4, CD81 HTR2A 4074/4885HTR2B 4082/4885KCNH2 4643/4885
US-20160311838-A1 PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME PHPT1, CD4, HCLS1 HTR2A 3773/4885HTR2B 3746/4885KCNH2 4338/4885
US-20220220134-A1 PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME PHPT1, CD4, CD81 HTR2A 4074/4885HTR2B 4082/4885KCNH2 4643/4885
US-10351581-B2 Phosphohistidine mimetics and antibodies to same PHPT1, CD4, HCLS1 HTR2A 3773/4885HTR2B 3746/4885KCNH2 4338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.